IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Costantino who wrote (282)	1/14/1997 10:38:00 PM
From: I. Luttichuys	of 1762

Hello Rick, Thanks for that post. That is some good info. I have tests tomorrow so, unfortunately, I will have to wait until say Friday to comment intelligently on this stuff. A couple of points though I wanted to make... Like yourself, I was first drawn to IDEC because of C2B8 however, CE9.1 is going to be the big event here. As I have pointed out before this drug is going to find an enormous market. You are correct in your observations about the care and expense SmithKline is going through here. I think they are pretty excited over the Phase II results. They were outstanding. I know I've said it before but, there is a reason a rheumatoid arthritis drug like this has been called the Holy Grail of pharmaceuticals. If Phase III shows efficacy as seen in Phase II, I think we will have a home run. This will overshadow C2B8 IMO. I am to the point with IDEC where I like the company and all my excitement is over how they will do. I find myself not worrying much if at all anymore about the stock in the short term (although I'm pretty bullish). These guys just really seem to have their act together. Speaking of the stock... I think you are correct about a turnaround at this point. In e-mail to you I may have mentioned I was considering some moves to be made on Monday (last). I actually did execute these so I have put my money where my mouth is. I believe the drop we saw on that recent day may have even been a shock wave from the Amgen/Regeneron fiasco. Reminded weaker hands what a failed trial will do to a young biotech. Have a good evening, BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next